His clinical research focuses on lipids and biomarkers of inflammation and thrombosis in stable coronary artery disease and acute coronary syndromes. In addition, he devotes his time on basic research regarding the interplay of innate immunity and thrombosis in critical ill patients and in the pathogenesis of atherosclerosis and acute coronary events.